skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 2,999  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: European Journal Of Clinical Pharmacology remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Correction to: The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta‑analysis
Correction to: The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta‑analysis
Material Type:
Article 		Add to My Research

Correction to: The risk of congenital heart defects associated with corticosteroids use during the first trimester of pregnancy: a systematic review and meta‑analysis

European journal of clinical pharmacology, 2023, Vol.79 (1), p.13-13 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;Springer-Verlag GmbH Germany, part of Springer Nature 2022. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-022-03429-5 ;PMID: 36416939

Full text available

Citations Cited by
2
Correction to: Trends and variation in benzodiazepine use in nursing homes in the USA
Correction to: Trends and variation in benzodiazepine use in nursing homes in the USA
Material Type:
Article 		Add to My Research

Correction to: Trends and variation in benzodiazepine use in nursing homes in the USA

European journal of clinical pharmacology, 2022-10, Vol.78 (10), p.1709-1709 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;Springer-Verlag GmbH Germany, part of Springer Nature 2022. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-022-03360-9

Full text available

Citations Cited by
3
Correction to: Prevalence and patient‑rated relevance of complexity factors in medication regimens of community dwelling patients with polypharmacy
Correction to: Prevalence and patient‑rated relevance of complexity factors in medication regimens of community dwelling patients with polypharmacy
Material Type:
Article 		Add to My Research

Correction to: Prevalence and patient‑rated relevance of complexity factors in medication regimens of community dwelling patients with polypharmacy

European journal of clinical pharmacology, 2022-08, Vol.78 (8), p.1363-1363 [Peer Reviewed Journal]

The Author(s) 2022 ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-022-03342-x ;PMID: 35650453

Full text available

Citations Cited by
4
Correction to: Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis
Correction to: Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis
Material Type:
Article 		Add to My Research

Correction to: Acid suppressant use in association with incidence and severe outcomes of COVID‑19: a systematic review and meta‑analysis

European journal of clinical pharmacology, 2022-08, Vol.78 (8), p.1361-1361 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;Springer-Verlag GmbH Germany, part of Springer Nature 2022. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-022-03335-w ;PMID: 35578041

Full text available

Citations Cited by
5
Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis
Material Type:
Article 		Add to My Research

Correction to: Plasma concentrations of remdesivir metabolite in a critical COVID-19 patient needing continuous venovenous haemodialysis

European journal of clinical pharmacology, 2022-05, Vol.78 (5), p.895-895 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2022 ;Springer-Verlag GmbH Germany, part of Springer Nature 2022. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-022-03305-2 ;PMID: 35238962

Full text available

Citations Cited by
6
Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy
Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy
Material Type:
Article 		Add to My Research

Correction to: Population pharmacokinetics‑pharmacodynamics of fondaparinux in dialysis‑dependent chronic kidney disease patients undergoing chronic renal replacement therapy

European journal of clinical pharmacology, 2022, Vol.78 (1), p.99-99 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03220-y ;PMID: 34528123

Full text available

Citations Cited by
7
Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment
Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment
Material Type:
Article 		Add to My Research

Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment

European journal of clinical pharmacology, 2022, Vol.78 (1), p.75-75 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03211-z ;PMID: 34494163

Full text available

Citations Cited by
8
Correction to: Evaluation of drug‑drug interactions of pemigatinib in healthy participants
Correction to: Evaluation of drug‑drug interactions of pemigatinib in healthy participants
Material Type:
Article 		Add to My Research

Correction to: Evaluation of drug‑drug interactions of pemigatinib in healthy participants

European journal of clinical pharmacology, 2021-12, Vol.77 (12), p.1899-1899 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03198-7

Full text available

Citations Cited by
9
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials
Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials
Material Type:
Article 		Add to My Research

Correction to: Current evidence on the impact of medication optimization or pharmacological interventions on frailty or aspects of frailty: a systematic review of randomized controlled trials

European journal of clinical pharmacology, 2021-10, Vol.77 (10), p.1593-1594 [Peer Reviewed Journal]

The Author(s) 2021 ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03166-1 ;PMID: 34363520

Full text available

Citations Cited by
10
Correction to: Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19
Correction to: Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19
Material Type:
Article 		Add to My Research

Correction to: Essentials in saline pharmacology for nasal or respiratory hygiene in times of COVID-19

European journal of clinical pharmacology, 2021-09, Vol.77 (9), p.1295-1295 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03141-w ;PMID: 33893861

Full text available

Citations Cited by
11
Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride
Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride
Material Type:
Article 		Add to My Research

Correction to: Estimation of a preliminary therapeutic reference range for children and adolescents with tic disorders treated with tiapride

European journal of clinical pharmacology, 2021-08, Vol.77 (8), p.1257-1257 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03159-0 ;PMID: 34047799

Full text available

Citations Cited by
12
Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome
Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome
Material Type:
Article 		Add to My Research

Correction to: CYP3A5 and CYP3A7 genetic polymorphisms affect tacrolimus concentration in pediatric patients with nephrotic syndrome

European journal of clinical pharmacology, 2021-08, Vol.77 (8), p.1251-1252 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-020-02875-3 ;PMID: 33515077

Full text available

Citations Cited by
13
Correction to: Iron chelation may harm patients with COVID-19
Correction to: Iron chelation may harm patients with COVID-19
Material Type:
Article 		Add to My Research

Correction to: Iron chelation may harm patients with COVID-19

European journal of clinical pharmacology, 2021-08, Vol.77 (8), p.1255-1255 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03124-x ;PMID: 33730195

Full text available

Citations Cited by
14
Correction to: Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria
Correction to: Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria
Material Type:
Article 		Add to My Research

Correction to: Potentially inappropriate medication in acute hospitalized elderly patients with polypharmacy: an observational study comparing PRISCUS, STOPP, and Beers criteria

European journal of clinical pharmacology, 2021-08, Vol.77 (8), p.1253-1253 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03103-2 ;PMID: 33538883

Full text available

Citations Cited by
15
Correction to: Pharmacological evaluation of prophylactic anti-microbial use in laparoscopic cholecystectomy; an open labelled study evaluating the concentrations of single dose intravenous ceftriaxone at serum and tissue level
Correction to: Pharmacological evaluation of prophylactic anti-microbial use in laparoscopic cholecystectomy; an open labelled study evaluating the concentrations of single dose intravenous ceftriaxone at serum and tissue level
Material Type:
Article 		Add to My Research

Correction to: Pharmacological evaluation of prophylactic anti-microbial use in laparoscopic cholecystectomy; an open labelled study evaluating the concentrations of single dose intravenous ceftriaxone at serum and tissue level

European journal of clinical pharmacology, 2021-07, Vol.77 (7), p.1017-1017 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03140-x ;PMID: 34019144

Full text available

Citations Cited by
16
Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants
Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants
Material Type:
Article 		Add to My Research

Correction to: An open-label, positron emission tomography study of the striatal D2/D3 receptor occupancy and pharmacokinetics of single-dose oral brexpiprazole in healthy participants

European journal of clinical pharmacology, 2021-06, Vol.77 (6), p.939-939 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-020-03071-z ;PMID: 33394055

Full text available

Citations Cited by
17
Retraction Note: Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children
Retraction Note: Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children
Material Type:
Article 		Add to My Research

Retraction Note: Efficacy of vitamin C for the prevention and treatment of upper respiratory tract infection. A meta-analysis in children

European journal of clinical pharmacology, 2021-06, Vol.77 (6), p.941-941 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03150-9 ;PMID: 33988724

Full text available

Citations Cited by
18
Therapeutic drug monitoring of oral targeted antineoplastic drugs
Therapeutic drug monitoring of oral targeted antineoplastic drugs
Material Type:
Article 		Add to My Research

Therapeutic drug monitoring of oral targeted antineoplastic drugs

European journal of clinical pharmacology, 2021-04, Vol.77 (4), p.441-464 [Peer Reviewed Journal]

The Author(s) 2020. corrected publication 2020 ;The Author(s) 2020. corrected publication 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020, corrected publication 2020 ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-020-03014-8 ;PMID: 33165648

Full text available

Citations Cited by
19
Correction to: Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial
Correction to: Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial
Material Type:
Article 		Add to My Research

Correction to: Protective effect of flumazenil infusion in severe acute benzodiazepine toxicity: a pilot randomized trial

European journal of clinical pharmacology, 2021-04, Vol.77 (4), p.555-556 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2021 ;Springer-Verlag GmbH Germany, part of Springer Nature 2021. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-021-03117-w ;PMID: 33635382

Full text available

Citations Cited by
20
Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs
Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs
Material Type:
Article 		Add to My Research

Correction to: Therapeutic drug monitoring of oral targeted antineoplastic drugs

European journal of clinical pharmacology, 2021-04, Vol.77 (4), p.465-465 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;ISSN: 0031-6970 ;EISSN: 1432-1041 ;DOI: 10.1007/s00228-020-03067-9 ;PMID: 33320282

Full text available

Citations Cited by

Results 1 - 20 of 2,999  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2010  (333)
  2. 2010 To 2012  (548)
  3. 2013 To 2015  (615)
  4. 2016 To 2019  (768)
  5. After 2019  (736)
  6. More options open sub menu

Language 

  1. Japanese  (333)
  2. Norwegian  (11)
  3. Russian  (4)
  4. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait